X0508 4 2026-02-11 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001310683 Culley Brian M C/O LINEAGE CELL THERAPEUTICS 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 true true false false President and CEO false Common Shares 2026-02-11 4 M false 31250 A 253385 D Common Shares 2026-02-11 4 F false 12869 1.80 D 240516 D Restricted Stock Units 0 2026-02-11 4 M false 31250 0 D Common Shares 31250 0 D Shares earned by the Reporting Person as a result of the vesting of a portion of Restricted Stock Units ("RSUs") granted to the Reporting Person on February 11, 2022. RSUs convert into common shares on a one-for-one basis. Does not include RSUs that may be settled in shares of the issuer's common stock that have not vested as of the date hereof or shares that may be acquired upon the exercise of certain stock options. Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 31,250 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction The Reporting Person was granted 124,997 RSUs on February 11, 2022, that vested with respect to approximately 25% of the shares subject to the award on each of February 11, 2023, 2024, 2025 and 2026. /s/ Brian M. Culley 2026-02-13